Kessler Foundation scientists to share new findings at international multiple sclerosis congress

Kessler Foundation's experts in cognitive research in multiple sclerosis to share new research findings at international meeting in Bordeaux, France

Kessler Foundation will be represented by four scientists at the inaugural International Congress on Cognition in Multiple Sclerosis to be held at the Congress Center in Bordeaux, France on May 11 & 12, 2012. John DeLuca, PhD, the Foundation's VP of Research and Training will attend with research scientists Victoria Leavitt, PhD, Lauren Strober, PhD, and James Sumowski, PhD. Kessler Foundation is known for rehabilitation research in cognition and mobility. MS research at Kessler Foundation is conducted in the Neuropsychology & Neuroscience Laboratory under the direction of Nancy Chiaravalloti, PhD.

"Cognitive impairment is a significant cause of disability in MS," said Dr. DeLuca. "We are pleased to join with our colleagues in the global community to work toward effective preventive and therapeutic strategies. At Kessler Foundation, our interest extends to the impact of cognitive difficulties on employment, a major consideration in this relatively young patient population." Dr. Leavitt will present her research on predictors of memory decline in MS; Dr. Strober 's topic is cognitive predictors of unemployment among people with MS and Dr. Sumowski will discuss the protective effect of intellectual enrichment against cognitive impairment , a finding in MS that was demonstrated for the first time at Kessler Foundation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study could lead to a more potent treatment option for multiple sclerosis